Study details
Enrolling now
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
Wake Forest University Health Sciences
NCT IDNCT04427709ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
38
Study length
about 6.1 years
Ages
18–75
Locations
1 site in NC
About this study
Researchers are testing if oxytocin, given by injection, affects your parasympathetic nervous system. The parasympathetic nervous system helps conserve energy in your body. The trial will measure how well this model works.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Oxytocin
- 2.Take Placebo
PhasePhase 2
DrugOxytocin
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
oxytocin (Hormone; causes uterine contractions)
Body systems
Musculoskeletal